Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms

Virology

Volumn 247, Issue 2, 1998, Pages 265-273

  Korth, Marcus J ^a   Taylor, Matthew D ^a   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032145604     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9249     Document Type: Article

References (40)

1. Agy M. B., Acker R. L., Sherbert C. H., Katze M. G. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cells by distinct mechanisms: Evidence for decreased stability and aberrant processing of HIV-1 proteins. Virology. 214:1995;379-386.
2. Agy M. B., Foy K., Gale M. J., Benveniste R. E., Clark E. A., Katze M. G. Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne. Virology. 183:1991;170-180.
3. Agy M. B., Wambach M., Foy K., Katze M. G. Expression of cellular genes in CD4-positive lymphoid cells infected by the human immunodeficiency virus, HIV-1: Evidence for a host protein synthesis shutoff induced by cellular mRNA degradation. Virology. 177:1990;251-258.
4. Ausubel, F. M. Brent, R. Kingston, R. E. Moore, D. D. Seidman, J. G. Smith, J. A. Struhl, K. 1988, Current Protocols in Molecular Biology, Greene Publishing and Wiley Interscience, New York.
5. Baca-Regen L., Heinzinger N., Stevenson M., Gendelman H. E. Alpha interferon-induced antiretroviral activities: Restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J. Virol. 68:1995;7559-7565.
6. Balzarini J., DeClercq E., Uberla K. SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaques. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:1997;1-4.
7. Balzarini J., Weeger M., Camarasa M. J., DeClercq E., Uberla K. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors. Biochem. Biophys. Res. Commun. 211:1995;850-860.
8. Chackerian B., Long E. M., Luciw P. A., Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71:1997;3932-3939.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Clements J. E., Zink M. C. Molecular biology and pathogenesis of animal lentivirus infections. Clin. Microbiol. Rev. 9:1996;100-117.
11. Coccia E. M., Krust B., Hovanessian A. G. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J. Biol. Chem. 269:1994;23087-23094.
12. Fernie B. F., Poli G., Fauci A. S. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells. J. Virol. 65:1991;3968-3971.
13. Gale M. Jr., Katze M. G. What happens inside lentivirus or influenza virus infected cells: Insights into regulation of cellular and viral protein synthesis. Methods: Companion Methods Enzymol. 11:1997;383-401.
14. Greenberg M. E., Ziff E. B. Stimulation of 3T3 cells induces transcription of the C-fos proto-oncogene. Nature. 311:1984;433-438.
15. Groudine M., Peretz M., Weintraub H. Transcriptional regulation of hemoglobin switching in chicken embryos. Mol. Cell. Biol. 1:1981;281-288.
16. Hansen B. D., Nara P. L., Maheshwari R. K., Sidhu G. S., Bernbaum J. G., Hoekzema D., Meltzer M. S., Gendelman H. E. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J. Virol. 66:1995;7543-7548.
17. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:1967;365-369.
18. Hovanessian A. G. Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′,5′-oligoadenylate synthetases. J. Interferon Res. 1:1991;199-205.
19. Hoxie J. A., Haggarty B. S., Bonser S. E., Rackowski J. L., Shan H., Kanki P. J. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): Evidence for CD4-associated molecules required for infection. J. Virol. 62:1988;2557-2568.
20. Javaherian K., Langlois A. J., Schmidt S., Kaufmann M., Cates N., Langeduk J. P. M., Meloen R. H., Desrosiers R. C., Burns D. P. W., Bolognesi D. P., LaRosa G. J., Putney S. D. The principal neutralization determininant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 89:1992;1418-1422.
21. Katze M. G. Regulation of the interferon-induced PKR: Can viruses cope. Trends Microbiol. 3:1995;75-78.
22. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
23. mac. J. Acquired Immune Defic. Syndr. 5:1992;639-646.
24. Li J. T., Halloran M., Lord C. I., Watson A., Ranchalis J., Fung M., Letvin N. L., Sodroski J. G. Persistent infection of macaques with simian-human immunodeficiency viruses. J. Virol. 69:1995;7061-7071.
25. Lu Y., Salvato M. S., Pauza C. D., Li J., Sodroski J., Manson K., Wyand M., Letvin N., Jenkins S., Touzjian N., Chutkowski C., Kushner N., LeFaile M., Payne L. G., Roberts B. Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:1996;99-106.
26. Luciw P. A., Pratt-Lowe E., Shaw K. E. S., Levy J. A., Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA. 92:1995;7490-7494.
27. Pitha P. M. Multiple effects of interferon on the replicationof human immunodeficiency virus type 1. Antiviral Res. 24:1994;205-219.
28. Sen G. C., Lengyel P. The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem. 267:1992;5017-5020.
29. Sen G. C., Ransohoff R. M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57-102.
30. Shirazi Y., Pitha P. M. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J.Virol. 66:1992;1321-1328.
31. Silverman R. H. Fascination with 2-5A-dependent RNase: A unique enzyme that functions in interferon action. J. Interferon Res. 14:1994;101-104.
32. Staehli P. Interferon induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200.
33. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolf B., Peichl P., Palfi G., Schnitzel W., Mlynar E., Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication. J. Virol. 69:1995;814-824.
34. Stevenson M., Stanwick T. L., Dempsey M. P., Lamonica C. A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1990;1551-1560.
35. Tang N. M., Ho C. Y., Katze M. G. The 58-kDa cellular inhibitor of the double stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ motifs to stimulate protein synthesisin vivo. J. Biol. Chem. 271:1996;28660-28666.
36. Taylor M. D., Korth M. J., Katze M. G. Interferon treatment inhibits the replication of simian immunodeficiency virus at an early stage: Evidence for a block between attachment and reverse transcription. Virology. 241:1998;156-162.
37. Varmus, H. E. Swanstrom, R. 1984, Replication of retrovirvses, In, RNA Tumor Viruses, 75, 134, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:1992a;7193-7200.
39. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:1992b;226-234.
40. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2′-5′A-dependent RNAse: A uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.